UBS Group
IVDAW icon

UBS Group’s Iveda Solutions Warrant IVDAW Stock Holding History

UBS Group’s Portfolio IVDAW Stock Details IVDAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$254 Sell
6,201
-10
-0.2% -$1 ﹤0.01% 9997
2025
Q4 		$497 Sell
6,211
-18,022
-74% -$2.81K ﹤0.01% 9932
2025
Q3 		$2.91K Buy
24,233
+2,047
+9% +$249 ﹤0.01% 9113
2025
Q2 		$2.88K Sell
22,186
-7,114
-24% -$936 ﹤0.01% 9411
2025
Q1 		$4.28K Buy
+29,300
New +$5.25K ﹤0.01% 9122
2023
Q1 		– Sell
-2,584
Closed -$310 – 9962
2022
Q4 		$310 Sell
2,584
-717
-22% -$99 ﹤0.01% 10257
2022
Q3 		$1K Hold
3,301
– – ﹤0.01% 9972
2022
Q2 		$1K Buy
+3,301
New +$1.49K ﹤0.01% 9889

Other funds holding IVDAW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group's IVDAW Position: Q1 2026 in Review

UBS Group reduced its Iveda Solutions Warrant (IVDAW) stake by 0.16% in Q1 2026, selling an estimated $1 and leaving 6,201 shares worth $254. The position accounts for ﹤0.01% of the portfolio, ranked #9997.

UBS Group first reported a position in IVDAW in Q2 2022 and has held it in 8 quarters since. The position peaked at $4.28K in Q1 2025. 6 funds tracked by Wall St. Rank hold IVDAW as of Q1 2026.

  • UBS Group held 6,201 shares of Iveda Solutions Warrant worth $254 as of Q1 2026.
  • UBS Group sold 10 Iveda Solutions Warrant shares in Q1 2026, an estimated $1.
  • Iveda Solutions Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9997 holding.
  • UBS Group first reported a position in Iveda Solutions Warrant in Q2 2022 and has held it in 8 quarters since.
  • UBS Group's Iveda Solutions Warrant position peaked at $4.28K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Iveda Solutions Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.